Article Sidebar
Views pdf: 38
RESULTS OF MELASMA TREATMENT WITH PICOSECOND YAG 1064 NM LASER AT HANOI DERMATOLOGY HOSPITAL
Main Article Content
Abstract
Objective: To evaluate the results and safety of 1064 nm Pico Nd:YAG Laser in the treatment of melasma at Hanoi Dermatology Hospital in 2021-2022. Subjects and methods: Prospective study, clinical intervention on 18 female patients ≥ 25 years old, diagnosed with melasma, treated at Hanoi Dermatology Hospital (April 2021–March 2022). Patients were exposed to 1064 nm Pico Nd:YAG Laser in 6 sessions, 2 weeks apart. The results were assessed by MASI index, Von Luschan scale, satisfaction level and side effects recorded. Results: The average age of patients was 42.9 ± 6.3 years; all were female. Mixed melasma accounted for 55.6%. The average MASI decreased from 7.20 ± 4.54 before treatment to 2.90 ± 1.84 after 6 sessions, a decrease of 59.7%. After 6 sessions, 88.9% of patients achieved “Good/very good” improvement according to the Von Luschan scale. 100% of patients were satisfied, of which 55.6% were very satisfied. No serious side effects were recorded. Conclusion: Pico Nd:YAG 1064 nm laser is an effective and safe method for treating melasma, with high satisfaction and few side effects.
Article Details
Keywords
Melasma; Pico Nd:YAG 1064 nm; Picosecond laser
References
2. Kwon SH, Hwang YJ, Lee SK, Park KC. Heterogeneous pathology of melasma and its clinical implications. Int J Mol Sci. 2016; 17(6):824.
3. Wu DC, Goldman MP, Wat H, Chan HH. A systematic review of picosecond laser in dermatology. Lasers Surg Med. 2021;53(1):9-49.
4. Choi YJ, Nam JH, Kim JY, et al. Efficacy and safety of a novel picosecond laser using 1064 and 595 nm on patients with melasma. Lasers Surg Med. 2017;49(10):899-907.
5. Hong JK, Shin SH, Park SJ, et al. Split-face study comparing 1064-nm picosecond and Q-switched Nd:YAG laser toning in melasma. J Dermatol Treat. 2022;33(6):1-9.
6. Lee MC, Lin YF, Hu S, et al. Comparison of picosecond alexandrite laser and Q-switched Nd:YAG laser in the treatment of melasma in Asians. Lasers Med Sci. 2018;33(8):1733-1738.
7. Pandya AG, Berneburg M, Ortonne JP. Guidelines for clinical trials in melasma: Pigmentary Disorders Academy. Br J Dermatol. 2006;156(Suppl 1):21-28.
8. Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched 1064-nm Nd:YAG laser for facial melasma in Asians: a randomized, split-face study. Lasers Surg Med. 2010;42(2):97-102.